Khan Najat Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$202,172.88

Insider Activity of Khan Najat

According to the SEC Form 4 filings, Khan Najat, being in a position of

  1. CEO and President at Recursion Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 198697 shares for $806,534,
    over all time since 2025-08-18, has bought 0 shares, and sold 235296 shares for $1.01M.

Biography of Khan Najat

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $806,5344100

Comparison of Insiders on Amount of Buys and Sells

2026-09-08SaleRecursion Pharmaceuticals, Inc.
RXRX
CEO and President
22,408
0.0043%
$3.52$78,822+11.34%
2026-06-05SaleRecursion Pharmaceuticals, Inc.
RXRX
CEO and President
23,588
0.005%
$3.58$84,459+3.16%
2026-03-09SaleRecursion Pharmaceuticals, Inc.
RXRX
CEO and President
28,298
0.0061%
$3.35$94,660-3.85%
2025-12-22SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief R&D Commercial Officer
124,403
0.0312%
$4.41$548,592-20.68%
2025-08-18SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief R&D Commercial Officer
36,599
0.0086%
$5.52$202,173-31.52%
Total: 5
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.